Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Isolated growth hormone deficiency type II (IGHD2) is mainly caused by heterozygous splice-site mutations in intron 3 of the GH1 gene.
|
31436800 |
2019 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GermlineCausalMutation
|
disease |
ORPHANET |
Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).
|
22139958 |
2012 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genetic forms of hypopituitarism and their manifestation in the neonatal period.
|
19762173 |
2009 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
The majority of mutations that cause isolated growth hormone deficiency type II are the result of aberrant splicing of transcripts encoding human growth hormone.
|
18586677 |
2008 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
A clinical variability in the severity of the IGHD II phenotype depending on the GH-1 gene alteration has been reported, and in vitro and transgenic animal data suggest that the onset and severity of the phenotype relates to the proportion of 17.5-kDa produced.
|
17038549 |
2007 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Isolated growth hormone deficiency type II (IGHD II) is characterized by short stature due to dominant-negative mutations of the human growth hormone gene (GH1).
|
12720086 |
2003 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Autosomal dominant GH deficiency due to an Arg183His GH-1 gene mutation: clinical and molecular evidence of impaired regulated GH secretion.
|
11502836 |
2001 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Detection of growth hormone gene defects by dideoxy fingerprinting (ddF).
|
9152628 |
1997 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Point mutations of the donor splice site of intron 3 of the human GH-1 gene cause autosomal dominant inherited isolated growth hormone deficiency (IGHD II).
|
8923859 |
1996 |
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
Biomarker
|
disease |
CTD_human |
|
|
|
Isolated Growth Hormone Deficiency, Type II
|
0.750 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PITUITARY DWARFISM I
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Phenotype-genotype correlations in congenital isolated growth hormone deficiency (IGHD).
|
22139958 |
2012 |
PITUITARY DWARFISM I
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Type IA isolated growth hormone deficiency (IGHD) consistent with compound heterozygous deletions of 6.7 and 7.6 Kb at the GH1 gene locus.
|
23295298 |
2012 |
PITUITARY DWARFISM I
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genetic forms of hypopituitarism and their manifestation in the neonatal period.
|
19762173 |
2009 |
PITUITARY DWARFISM I
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Treatment of isolated growth hormone deficiency type IA due to GH-I gene deletion with recombinant human insulin-like growth factor I.
|
7509217 |
1993 |
PITUITARY DWARFISM I
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PITUITARY DWARFISM I
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
PITUITARY DWARFISM I
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Kowarski syndrome
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature.
|
17519310 |
2007 |
Kowarski syndrome
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Short stature caused by a biologically inactive mutant growth hormone (GH-C53S).
|
15713716 |
2005 |
Kowarski syndrome
|
0.710 |
Biomarker
|
disease |
BEFREE |
It should be noted that the child in this study is not a typical case of Kowarski syndrome in which endogenous GH is found to be simply bioinactive, as in the patient we recently described elsewhere.
|
9554469 |
1998 |
Kowarski syndrome
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Biologically inactive growth hormone caused by an amino acid substitution.
|
9276733 |
1997 |
Kowarski syndrome
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Biologically inactive growth hormone caused by an amino acid substitution.
|
9276733 |
1997 |
Kowarski syndrome
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Brief report: short stature caused by a mutant growth hormone.
|
8552145 |
1996 |